0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
This Week in JAMA |

This Week in JAMA FREE

JAMA. 2006;295(8):859. doi:10.1001/jama.295.8.859.
Text Size: A A A
Published online

-EXPRESS

The adamantanes, amantadine and rimantadine, are commonly recommended to prevent and treat influenza A virus infections; however, since the mid-1990s, increasing rates of resistance to the adamantanes have been documented. In an analysis of influenza isolates from patients in 26 states that were collected from October 1 through December 31, 2005, Bright and colleaguesArticle found that 193 (92%) of 209 influenza A(H3N2) viruses and 2 (25%) of 8 influenza A(H1N1) viruses analyzed had mutations that confer adamantane resistance. In an editorial, Weinstock and ZuccottiArticle discuss reasons for the increase in adamantane resistance and the need for immediate, worldwide intervention.

DRUG-ELUTING STENTS FOR NEW CORONARY ARTERY LESIONS

Compared with bare metal stents, sirolimus-eluting and paclitaxel-eluting stents markedly reduce the risk of late luminal loss after percutaneous coronary revascularization, but it is not clear if one drug-eluting stent is superior to the other. Morice and colleaguesArticle report results of the multicenter, randomized REALITY trial, which compared the safety and efficacy of a sirolimus-eluting stent vs a paclitaxel-eluting stent in patients with de novo coronary artery lesions. Comparing outcomes by type of drug-eluting stent, the trial investigators found no differences in in-lesion binary restenosis at 8 months, 1-year rates of target lesion and vessel revascularization, or a composite end point of major adverse cardiac events. In an editorial, BrenerArticle discusses what is known and what remains to be determined about the effects of drug-eluting stents.

BOARD CERTIFICATION IN HOSPITALS AND HEALTH PLANS

Specialty board certification is a potential measure of physician competence. In 2 articles in this issue of JAMA, Freed and colleaguesArticleArticle, who are members of the Research Advisory Committee of the American Board of Pediatrics, report results from telephone surveys of hospital and health plan credentialing personnel that examined the role of board certification and recertification in decisions about hospital privileges and health plan credentialing. The authors found that 78% of the hospitals did not require pediatricians to be board certified at initial privileging although 70% required certification at some point during pediatricians' tenure. Among health plans, the authors found that 90% do not require board certification at initial credentialing and 41% required general pediatricians and 40% pediatric subspecialists to be board certified at some point. In an editorial, Cassel and HolmboeArticle discuss the roles of board certification and recertification and monitoring of physician performance in ensuring quality medical care.

HELMET USE AND RISK OF HEAD INJURY IN ALPINE SPORTS

Head injuries are common in alpine skiers and snowboarders, but whether helmets can reduce head injuries is not clear. In a case-control study of skiers and snowboarders in Norway, Sulheim and colleagues assessed the effect of wearing a helmet on the risk of head injury. In analyses that controlled for other potential head injury risk factors, the authors found that helmet use was associated with reduced risk of head injury among alpine skiers and snowboarders.

A PIECE OF MY MIND

“Within him I sense an eagerness to talk; within myself, a desire, and perhaps an obligation, to listen.” From “Doctors Need Doctors Too.”

MEDICAL NEWS & PERSPECTIVES

Waning immunity after childhood pertussis vaccination has led to a resurgence of this infectious disease. But a newer and safer pertussis vaccine, added to existing tetanus/diphtheria boosters, is now recommended for adolescents and most adults.

CLINICIAN'S CORNER

Mrs G is a 54-year-old woman who has a several-year history of abdominal pain and discomfort associated with constipation. Lembo discusses the diagnosis of irritable bowel syndrome (IBS), possible causes of constipation-predominant IBS, and its treatment.

AUTHOR IN THE ROOM TELECONFERENCE

Join Anna Taddio, PhD, on Wednesday, March 15, 2006, from 2 to 3 PM eastern time to discuss her study of systemic analgesia and local anesthesia for procedural pain in neonates, published in the February 15, 2006, issue of JAMA . Author in the Room is a teleconference call between the author, JAMA readers, and experts in implementing practice change to help clinicians implement research into practice.

JAMA PATIENT PAGE

For your patients: Information about irritable bowel syndrome.

Tables

References

Letters

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.